Search by Drug Name or NDC

    NDC 69238-1621-01 metyrosine 250 mg/1 Details

    metyrosine 250 mg/1

    metyrosine is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals NY LLC. The primary component is METYROSINE.

    Product Information

    NDC 69238-1621
    Product ID 69238-1621_fe7e12ab-6604-4e78-94c1-e64237cd1289
    Associated GPIs 36300025000110
    GCN Sequence Number 000400
    GCN Sequence Number Description metyrosine CAPSULE 250 MG ORAL
    HIC3 A4Y
    HIC3 Description ANTIHYPERTENSIVES, MISCELLANEOUS
    GCN 01540
    HICL Sequence Number 000138
    HICL Sequence Number Description METYROSINE
    Brand/Generic Generic
    Proprietary Name metyrosine
    Proprietary Name Suffix n/a
    Non-Proprietary Name metyrosine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 250
    Active Ingredient Units mg/1
    Substance Name METYROSINE
    Labeler Name Amneal Pharmaceuticals NY LLC
    Pharmaceutical Class Catecholamine Synthesis Inhibitor [EPC], Catecholamine Synthesis Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA213734
    Listing Certified Through 2024-12-31

    Package

    NDC 69238-1621-01 (69238162101)

    NDC Package Code 69238-1621-1
    Billing NDC 69238162101
    Package 100 CAPSULE in 1 BOTTLE, PLASTIC (69238-1621-1)
    Marketing Start Date 2020-07-24
    NDC Exclude Flag N
    Pricing Information N/A